INTRODUCTION
In order to maintain the fidelity of genetic information, organisms have evolved surveillance mechanisms that monitor the integrity of the chromosomes. These conserved checkpoints comprise a network of regulatory signaling pathways that initiate downstream events principally aimed at repairing DNA lesions, while inducing a transient arrest in cell division (Weinert and Hartwell, 1988) .
Cell-cycle progression normally comprises a series of tightly integrated events initiated via differential activation of the cyclin-dependent kinases (CDKs). In budding yeast S. cerevisiae, entry into the cell-division cycle, termed START, is operationally defined as a point at which cells become committed to the mitotic cell cycle. This requires the accumulation of threshold levels of the G1 cyclins Cln1 and Cln2 (Tyers et al., 1992) . Activation of the CDK Cdc28 by cyclins signals a host of events that culminate in replication and the subsequent mitotic segregation of the chromosomes.
However, several stages in the cell cycle, including the G1-to-S phase transition, are subject to strict checkpoint arrest in response to both ectopic and endogenous sources of DNA damage. The significance of the G1 checkpoint arrest is highlighted by the observation that genes that function in G1 progression, or surveillance mechanisms that monitor its proper execution, are amongst the most commonly mutated genes found in human cancers (Sherr and McCormick, 2002) .
Progression through the G1 phase is normally tightly coupled to the rate of active protein synthesis (Polymenis and Schmidt, 1999) . Owing to its ubiquitous requirement in protein translation, the biogenesis of mature transfer RNA (tRNA) plays an intrinsic role in this process (Mann et al., 1992; Volta et al., 2005) . After its synthesis by RNA polymerase III, the primary tRNA transcripts undergo extensive processing (reviewed in [Hopper and Phizicky, 2003] ), which, in the case of intron-containing tRNAs, includes splicing. The yeast genome encodes 272 tRNA genes, of which 59, encoding 10 different tRNA species, contain introns (O'Connor and Peebles, 1991) . Splicing is a prerequisite for the biogenesis of functional tRNA because all introns disrupt the adjacent anticodon loops. Although tRNA processing occurs primarily in the nucleus, splicing in yeast is accomplished in the cytoplasm by a conserved heterotetrameric complex.
Using yeast as a model system, we report that downregulation of tRNA export represents a previously unanticipated physiological response to genotoxic stress. In the presence of DNA damage, Los1, the principal nuclear export factor for intron-containing tRNA, becomes differentially localized to the cytoplasm in a signal-dependent manner. This relocalization causes rapid accumulation of unspliced precursor tRNA in the nucleus in vivo because Los1 is limiting for the export process. The nuclear retention of tRNA autonomously signals the activation of the Gcn4 transcription factor, which, in turn, mediates the delayed accumulation of the key cell-cycle regulator cyclin Cln2 and the execution of a transient G1 arrest. Disruption of this regulatory network in null mutants of the upstream signaling components or the downstream effectors is associated with aberrant cell-cycle progression and enhanced loss of viability after DNA damage.
RESULTS

Downregulation of tRNA Splicing in Response to DNA Damage
Defects in cellular protein-synthesis machinery (Mann et al., 1992; Polymenis and Schmidt, 1999) , including those of the tRNA splicing components ( Figure S1 , see Supplemental Data available with this article online), are primarily manifested as a slow G1 progression. Since DNA damage also elicits a transient G1 arrest, we examined whether tRNA processing is subject to regulation during checkpoint-induced G1 arrest.
In yeast, the primary tRNA transcript undergoes 5 0 and 3 0 end removal in the nucleus and, in intron-containing species, splicing after export to the cytosol ( Figure 1A ). The subsequent ligation of the spliced exons gives rise to functionally mature tRNA. We monitored tRNA end processing and splicing by using oligonucleotide probes that hybridize specifically to the 5 0 or 3 0 splicing junctions of tRNA Ile UAU , as a representative tRNA, or to the intron itself. The results demonstrate that whereas end processing remains intact, there is an accumulation of introncontaining, but end-processed, tRNA after treatment with the DNA alkylating agent methylmethane sulfonate (MMS) ( Figure 1B ). The accumulation of this processing intermediate is a reflection of an in vivo defect in the splicing step (O'Connor and Peebles, 1991) . To confirm the causal basis for this effect, we exposed yeast cultures to UV irradiation, which induces DNA lesions distinct from those generated by MMS. Probing tRNA Ile revealed a similar defect in splicing in UV-irradiated cells, as seen after MMS treatment ( Figure 1C , upper row).
Since the splicing junctions in intron-containing tRNAs are not conserved and the introns themselves vary in sequence and length (Abelson et al., 1998) , we similarly probed several other intron-containing tRNAs to verify the ubiquity of the DNA-damage response. All newly transcribed tRNA species examined displayed comparable splicing defects after UV exposure ( Figure 1C ). The ratio of end-processed to primary tRNA transcript serves as a measure of in vivo splicing efficiency (O'Connor and Peebles, 1991) . Determining this ratio in tRNA Ile and tRNA Leu before and after DNA damage ( Figure 1D ) revealed that the in vivo defect in splicing after UV treatment was not intron specific, was comparable in magnitude, and occurred with similar kinetics. To ensure that the impaired tRNA splicing was not due to spurious effects of MMS or UV other than generating DNA lesions, we introduced genomic DNA double-strand breaks by heterologous expression of the restriction endonuclease EcoRI in vivo. A CEN-based plasmid that expresses EcoRI in the presence of galactose is known to activate DNA damage signaling (Mills et al., 1999) . Genomic DNA prepared from yeast cells grown in galactose that harbor this plasmid display lower average molecular weights as compared to glucose controls (Figure 2A, upper panel) , indicating the presence of sporadic DNA double-strand breaks. Importantly, these cells also displayed defective tRNA splicing similar in magnitude ( Figure 2A , lower panel, quantifications at the bottom) to that detected after exposure to UV. Collectively, these data demonstrate that tRNA splicing is impaired in cells with DNA damage.
The rapid inhibition of tRNA splicing in UV-irradiated cells ( Figure 1D ), which was complete within 15 min, indicated that it was not secondary to DNA-damage-induced cell-cycle arrest since the irradiated cells do not display a predominant cell-cycle phenotype within this time course (not shown). Consistent with this, wild-type cells arrested in early G1 by a-factor treatment exhibited wild-type splicing activity and, moreover, executed a UVinduced reduction in tRNA splicing similar to that observed in cycling cells ( Figure 2B ). The reduction in tRNA splicing after DNA damage was therefore not a passive consequence of the induction of cell-cycle arrest.
Downregulation of tRNA Splicing after DNA Damage Requires an Intact Signaling Pathway
The rapid kinetics of the inhibition of tRNA splicing ( Figure 1D ) was highly reminiscent of a signal-mediated response. Since much of the cellular response to DNA damage is mediated via conserved checkpoint signaling pathways, we explored this possibility by evaluating tRNA splicing after DNA damage in strains bearing null alleles of select genes encoding core components of the checkpoint signaling apparatus in yeast. We first examined in vivo tRNA splicing in strains that harbor deletion of RAD17, RAD24, or MEC3, which encode interacting subunits of a protein complex that functions as a DNA lesion sensor, and in a strain bearing a null allele of MEC1, which encodes a distinct sensor that functions in parallel (Majka and Burgers, 2005; Melo and Toczyski, 2002) . We also examined splicing in a mutant harboring a deletion of RAD53, which encodes the principal downstream signal transducer.
The rad17, rad24, and mec3 mutants maintained the ability to downregulate tRNA splicing after MMS treatment ( Figure 2C , left panel), indicating that none of these genes is singly required for activating this response. In contrast, the MMS-treated mec1 or rad53 mutants did not accumulate end-processed, intron-containing intermediates ( Figure 2C , right panel), indicating that the perturbation in tRNA splicing after DNA damage was Mec1/ Rad53-dependent.
The requirement for intact Mec1 and Rad53, the sequential components of a conserved DNA-damage signaling pathway, indicated that the downregulation of tRNA splicing is an active cellular response. Moreover, the unperturbed tRNA splicing activity exhibited by mec1D and rad53D mutants, which are highly sensitive to DNA damage, indicated that the impaired tRNA splicing activity exhibited by wild-type cells after exposure to MMS was not due to a simple loss of cellular viability after genotoxic stress. Checkpoint-Induced Inhibition of tRNA Splicing Is due to Defective tRNA Nuclear Export To determine the mechanism underlying the impaired tRNA splicing after DNA damage, we initially examined if the defective splicing was due to a reduction in the enzymatic activity of the basal tRNA splicing machinery. Using an in vitro tRNA splicing assay (Reyes and Abelson, 1987) that provided a qualitative reflection of in vivo splicing activity ( Figure S2A ), lysates prepared from control untreated or MMS-treated wild-type yeast displayed comparable activity over a range of protein concentrations (Figure S2B) . Moreover, the relative abundance of the Cterminally TAP-tagged enzymatic subunits Sen2 and Sen34 proteins was unperturbed after DNA damage (Figure S2C) , a finding in line with a previous report showing that the level of all four SEN gene transcripts remain unchanged after MMS treatment (Gasch et al., 2001 ). The accumulation of unspliced tRNA after DNA damage was therefore unlikely due to a reduction in the core enzymatic activity of the tRNA splicing machinery. Although tRNA is transcribed in the nucleus, the yeast splicing machinery is localized to the cytoplasm (Yoshihisa et al., 2003) . Consequently, mutations in the nuclear export machinery lead to the accumulation of intron-containing tRNA in the nucleus (Hellmuth et al., 1998; Simos and Hurt, 1999) . Therefore, we monitored the integrity of tRNA nuclear export after DNA damage. In a fluorescence in situ hybridization assay (FISH), the newly transcribed intron-containing tRNA Ile was predominantly localized to the nucleus during unperturbed growth ( Figure 3A ), a localization pattern in line with what was seen in a previous report (Sarkar and Hopper, 1998) . After MMS treatment, the wild-type cells displayed a more pronounced tRNA nuclear accumulation ( Figure 3A ). We determined the subcellular distribution of intron-containing tRNA Ile transcripts by rigorously quantifying the ratio of nuclear to cytoplasmic fluorescence (FITC) signals in a cell population (see Experimental Procedures for details). This quantitative approach confirmed that the precursor tRNA is nuclear enriched in MMS-treated cells ( Figure 3B ), thereby illustrating that the subcellular distribution of tRNA was subject to fine regulation in cells with DNA damage. The MMSinduced nuclear retention of newly transcribed tRNA in situ was correlated with the accumulation of unspliced tRNA in vivo ( Figure 2C , WT). Unlike the wild-type cells, the rad53 mutants did not exhibit differential tRNA nuclear accumulation after MMS treatment ( Figure 3C , quantified in Figure 3D ), in agreement with the observation that these mutants maintained the ongoing rate of tRNA splicing after DNA damage ( Figure 2C , rad53D). The Rad53-mediated sequestering of precursor transcripts in the nucleus provided a plausible mechanistic basis for the accumulation of unspliced tRNA in vivo after DNA damage in wildtype cells. The defect in nucleocytoplasmic trafficking was not ubiquitous because two intronless tRNAs, in addition to poly(A)-containing mRNA, maintained a persistent subcellular localization after MMS treatment ( Figure S3 ). The intact nucleocytoplasmic trafficking of these RNA species suggested that the nuclear accumulation of introncontaining tRNA after MMS was a targeted response, an observation that is in line with its requirement for a signaling pathway ( Figure 2C ).
The nuclear accumulation of tRNA after MMS treatment is not due to elevated synthesis of primary transcripts after DNA damage, because the polymerase III-directed tRNA transcription is globally downregulated after DNA damage in yeast (Ghavidel and Schultz, 2001 ). This raised the possibility that the nuclear retention of tRNA was due to its attenuated export from the nucleus.
As a member of the importin b family of karyopherins, yeast Los1 (Hopper et al., 1980) and its mammalian counterpart, exportin-t (Arts et al., 1998) , are the principal tRNA export receptors. In keeping with its gross defect in tRNA splicing in vivo ( Figure 4A ), los1 deletion mutants displayed a constitutive nuclear accumulation of introncontaining tRNA Ile UAU in unperturbed growth ( Figure 4B , quantifications in Figure 4C ). However, unlike the wildtype cells, induction of DNA damage in los1D cells did not enhance the basal defect in tRNA export ( Figure 4C ) or splicing ( Figure 4A , quantifications shown at the bottom). The failure to elicit a response in these mutants suggested that the nuclear accumulation of tRNA primary transcripts in wild-type cells after DNA damage was due to impaired function of the Los1 export factor.
Western blot of the whole-cell lysates from a strain with C-terminally TAP-tagged Los1 demonstrated that the apparent involvement of Los1 in defective tRNA export after DNA damage was not due to a reduction in its relative abundance ( Figure 4D ). Given the likelihood of Los1 nucleocytoplasmic shuttling (Hellmuth et al., 1998) , we examined its in situ localization both before and after DNA damage in cells harboring a C-terminally GFP-tagged allele of LOS1. Similar to its wild-type counterpart (Simos et al., 1996), and in keeping with its principal function as an export factor, Los1-GFP was predominantly localized to the nuclear periphery during normal growth in wild-type cells ( Figure 4E, left panel) . By contrast, a fraction of Los1-GFP became preferentially redistributed to the cytoplasm after exposure to MMS, giving rise to its homogenous cellular appearance ( Figure 4E, left panel) . In an independent experimental approach, parallel western blot examination of nuclear and cytosolic protein fractions prepared from TAP-tagged Los1 cells confirmed the differential relocalization of Los1 to the cytoplasm after MMS exposure ( Figure 4F ). In addition to Los1, we also examined the in situ localization of two other members of the yeast karyopherin b family, Kap111 and Kap122, along with that of Rna1, a Ran-specific GTPase-activating protein (Ran-GAP1), involved in RNA export. The apparent persistent in situ localization of the C-terminally GFP-tagged karyopherins to the nucleus and Rna1 to the cytoplasm (Figure 4G) suggested that the DNA-damage-induced relocalization of Los1 was a targeted response. Consistent with this, the nuclear localization of Los1-GFP remained unperturbed in MMS-treated rad53D mutants ( Figure 4E , right panel), demonstrating a requirement for Rad53-dependent signaling in mediating this response. The significance of the DNA-damage-induced Los1 relocalization was demonstrated by the observation that rad53D cells, which maintained a constitutive nuclear pool of Los1, displayed no obvious defect in tRNA export ( Figure 3C ) or splicing ( Figure 2C ) after MMS treatment. Collectively, these data indicate that the signal-mediated relocalization of Los1 from the nucleus was the likely determinant of the impaired tRNA export after DNA damage.
Constitutive Reduction in tRNA Export through LOS1 Deletion Restores the Impaired G1 Arrest and Enhances the Viability of rad53 Checkpoint Mutants Delay in progression through the G1 phase of the cell cycle is a hallmark of cells with unrepaired genomic lesions (Siede et al., 1994) . Although G1 arrest appears to be a transient delay en route to mitotic arrest, from a theoretical viewpoint, failure to delay cell-cycle progression before the initiation of DNA replication can lead to gross chromosomal anomalies (reviewed in Paulovich et al., 1997b) . Accordingly, premature progression through G1 partly accounts for the increased genomic instability in checkpoint mutants. We therefore examined whether the failure of rad53 mutants to downregulate tRNA export after DNA damage ( Figure 3D ) contributes to the defective G1 checkpoint execution in these mutants.
As a downstream target of Rad53 signaling ( Figure 4E ), LOS1 is functionally epistatic to RAD53 in downregulation of splicing, because mutation in either gene alone abolishes the MMS-induced reduction in tRNA splicing (Figures 2C and 4A) . We reasoned that deletion of LOS1 in a rad53 null mutant should functionally mimic its negative regulation by intact Rad53 signaling in MMS-treated wild-type cells. This experimental approach is of utility in deciphering the downstream effectors of signaling pathways. For instance, reducing histone gene dosage, a target of Rad53-mediated signaling that is normally degraded in wild-type cells after DNA damage, partially restores viability in a rad53 mutant (Gunjan and Verreault, 2003) .
A constitutive reduction in tRNA splicing via targeted deletion of LOS1 resulted in marked accumulation of unspliced tRNA in both rad53D and isogenic wild-type control strains ( Figure 5A , with relative quantifications indicated). In order to examine the integrity of the G1 checkpoint in these mutants, logarithmically growing (log) cells were blocked in G1 with a-factor, treated with MMS, and then released into fresh media. Cell-cycle progression was then monitored by FACS.
In the absence of DNA damage, all four strains displayed comparable rates of cell-cycle progression ( Figure 5B , cf. lanes 1, 3, 5, and 7) since arrest in response to, or recovery from, a-factor arrest is not checkpoint dependent. The MMS-treated wild-type cells displayed a prolonged G1 progression, indicated by the delay in accumulation of cells with a 2N DNA content ( Figure 5B , lanes 1 and 2). The intact Rad53-dependent signaling in wild-type cells normally impinges on Los1 and alters its nucleocytoplasmic distribution ( Figure 4E ). Accordingly, a los1 null mutant displayed a G1 delay ( Figure 5B , lanes 2 and 4) and viability ( Figure 5C ) comparable to that of the wildtype cells after MMS treatment.
Given the requirement for Rad53 signaling in the G1 checkpoint (Sidorova and Breeden, 1997) , the MMStreated rad53 null mutant exited G1 unimpeded, indicated by rapid accumulation of cells with a 2N DNA content (Figure 5B , cf. lanes 2 and 6). Remarkably, rad53D los1D double mutants displayed a G1 profile similar to that of the wild-type cells ( Figure 5B , cf. lanes 2, 6, and 8). In principle, deletion of LOS1, a negatively regulated downstream target of Rad53 in wild-type cells, acts as a suppressor of the defect in G1 checkpoint execution in a rad53 mutant. Concomitant with the restoration of the G1 checkpoint, there was a partial recovery in viability in the rad53D los1D double mutants after MMS treatment relative to the rad53D parental strain ( Figure 5C ).
In addition to prolonging G1 progression, treatment of yeast with MMS also delays DNA replication as a result of impaired firing of replication origins (Tercero et al., 2003) . Since determining the cellular DNA content by FACS does not distinguish between slow passage through START and delayed initiation of replication, we performed an a-factor trap experiment (Gerald et al., 2002) . Deletion of LOS1 extended the window of a-factor sensitivity in rad53D los1D double mutants after MMS treatment, demonstrating that Rad53-mediated downregulation of tRNA export is a determinant of progression through START ( Figure S5 ).
Downregulation of tRNA Export Contributes to G1 Arrest by Delaying Translation of Cln2
We sought to examine how impaired tRNA export contributes to the execution of the G1 checkpoint. In unperturbed growth, the G1 cyclins Cln1, Cln2, and Cln3 largely govern progression through START (Tyers et al., 1991) . In particular, the accumulation of Cln1 and Cln2 proteins to threshold levels precedes G1 progression. Given the clear delay in G1 progression in MMS-treated wild-type cells (Figure 5B, lanes 1 and 2) , we explored the possibility that a defect in the accumulation of the G1 cyclins plays a role in execution of the G1 checkpoint after DNA damage. To this end, we monitored the accumulation of Cln2 by quantitative western blot by using a Cln2-TAP strain that harbors a C-terminally TAP-tagged allele of CLN2 (Ghaemmaghami et al., 2003) . Cln2-TAP cells displayed wild-type growth rates (data not shown), and the canonical cell-cycle-regulated expression of Cln2 mRNA and protein ( Figures 6A and 6B, upper panels) .
In order to monitor the accumulation of Cln2-TAP after DNA damage, cells were synchronized in G1 by a-factor and then left unperturbed or treated with MMS. After release into fresh media to allow for resumption of the cell cycle, cells were harvested at the indicated time points, and whole-cell protein lysates and mRNA were prepared for analysis ( Figures 6A and 6B ). Since it was previously reported that the Cln2 mRNA level decreases after MMS treatment (Sidorova and Breeden, 1997) , we normalized Cln2-TAP protein abundance to that of its cognate mRNA in order to monitor the rate of Cln2-TAP protein translation independent of its transcript levels. Figure 6C depicts the quantification of Cln2-TAP protein accumulation after release from a-factor arrest. In untreated cells, Cln2-TAP protein steadily accumulated and was maximally expressed within 40 min after release, whereafter it declined sharply as cells exited G1 ( Figure 5B, lane 1) . By contrast, the accumulation of Cln2-TAP protein was markedly slower in MMS-treated cells ( Figure 6C ), coincident with the delayed G1 progression in these cells (Figure 5B, lane 2) . While we cannot rule out a role for transcriptional regulation of G1 cyclins as part of a broader cellular response, our data are consistent with the involvement of a posttranscriptional mechanism in regulating Cln2 expression. Notably, this delay was not due to aberrant proteolysis of Cln2 since the half-life of the G1 cyclins remains unchanged after genotoxic stress (Germain et al., 1997) .
The paralogous CLN1 and CLN2 genes are coordinately expressed throughout the cell cycle and function redundantly in G1 progression (Tyers et al., 1991) . Given their extensive functional and regulatory overlap, we anticipate that Cln1 expression is subject to a similar mode of translational regulation after DNA damage. Despite their apparent functional redundancy, Cln3 is distinct from Cln2 (and Cln1) both in its primary sequence and largely constitutive expression pattern throughout the cell cycle (Stuart and Wittenberg, 1994) . Therefore, we monitored the abundance of TAP-tagged Cln3 in parallel. In accordance with its constitutive cell-cycle expression, Cln3-TAP levels remained unchanged in a-factor-arrested cells ( Figure S6 ). Moreover, unlike Cln2-TAP, Cln3-TAP protein expression was undisturbed in MMS-treated cells (B) Delayed G1 progression in rad53D mutants by deleting LOS1. Logarithmically growing (log) cells were arrested in G1 by a-factor and were treated with MMS or left untreated. These cells were subsequently released into fresh media and analyzed by FACS.
(C) Reduction in MMS hypersensitivity of rad53D mutants by deleting LOS1. After MMS treatment, viability was determined by counting colonies after a 3 day incubation at 30 C.
( Figure S6 , quantifications in the lower panel). These results argue for a measure of specificity in the targeted perturbation in Cln2 protein translation after DNA damage. The delayed accumulation of Cln2 in MMS-treated wildtype cells was highly concordant with the transient G1 arrest in these cells ( Figure 5B, lanes 1and 2) . Since rad53D cells do not arrest in G1 after MMS treatment ( Figure 5B , cf. lanes 2 and 6), we reasoned that aberrant Cln2 accumulation may underlie the failure to execute a G1 checkpoint in these mutants. We therefore examined Cln2-TAP protein accumulation in untreated and MMS-treated rad53D cells after recovery from a-factor arrest.
In contrast to the wild-type cells, Cln2-TAP accumulated in MMS-treated rad53D cells with a kinetic profile indistinguishable from that observed in untreated cells ( Figure 6D ). Since Cln2 accumulation was comparable in the wild-type and the rad53 mutant during unperturbed growth, intact Rad53 signaling was specifically required for the delayed accumulation of Cln2-TAP after DNA damage ( Figure 6D , quantification in Figure 6E ). Remarkably, deletion of LOS1 in a rad53 null mutant delayed Cln2-TAP accumulation after MMS ( Figure 6D , quantification in Figure 6E ), while restoring the defective G1 checkpoint in these cells ( Figure 5B , cf. lanes 6 and 8). Collectively, these data provide evidence that Rad53-dependent regulation of tRNA export plays a key role in executing the G1 checkpoint by delaying the accumulation of the key cellcycle regulator Cln2.
Impaired tRNA Export Contributes to G1 Checkpoint via Activation of GCN4
We sought to examine how the attenuated nuclear export of intron-containing tRNA contributes to the delayed accumulation of Cln2 and the subsequent G1 arrest. Since the delay in Cln2 accumulation is primarily at the translation level, we reasoned that the defect in tRNA export leads to impaired translation by lowering the abundance of the mature tRNA pool available to the protein-synthesis machinery. Quantitative northern blot, however, revealed that the defect in flow of the intron-containing transcripts form the nucleus after UV or MMS treatment had no measurable impact on the level of cognate mature tRNAs ( Figure S7B ), a likely reflection of an inordinately long tRNA half-life (Colby et al., 1981) .
Physiological perturbations, such as nutritional or genotoxic stress, induce translational derepression of the ubiquitous transcription factor Gcn4, a response conserved from yeast to mammals (Dever et al., 1993; Engelberg et al., 1994) . Gcn4 activation reduces the rate of general protein synthesis while simultaneously increasing the expression of proteins whose functions are required under conditions of starvation or stress (reviewed in Hinnebusch and Natarajan, 2002) . Remarkably, aberrant tRNA accumulation in the nucleus in mutants with defects in tRNA processing or export also leads to translational derepression of Gcn4 in the cytoplasm (Qiu et al., 2000) . While the intermediary components of this response remain unknown, it is postulated that it serves as a nuclear surveillance system that detects defects in tRNA biogenesis and elicits a Gcn4-dependent reduction in the initiation step of protein translation. In particular, deletion of LOS1 leads to constitutive activation of Gcn4 (Qiu et al., 2000) . Hence, we investigated whether the less pronounced accumulation of intron-containing tRNA in nuclei of cells with DNA damage similarly induces activation of Gcn4.
We utilized a widely employed CEN-based reporter plasmid, carrying a GCN4 promoter driving the expression of a lacZ gene (GCN4-lacZ), that provided a quantitative measure of Gcn4 activity in a b-galactosidase assay (Dever et al., 1992) . Wild-type cells that harbor this heterologous plasmid displayed a basal b-galactosidase activity in vivo ( Figure 7A ). MMS treatment led to the expected Gcn4 activation, reflected in the increase in b-galactosidase activity ( Figure 7A ). The nearly 3-fold MMS-induced increase in plasmid-borne lacZ expression was in line with that in cells that harbor a genomic copy of GCN4-lacZ (Natarajan et al., 2001) . While rad53D mutants exhibited a level of b-galactosidase activity comparable to that of the wild-type in Figure 7 . Impaired tRNA Export Signals MMS-Induced G1 Arrest by Activating Gcn4 (A) b-galactosidase activity in strains that harbor a GCN4-lacZ reporter plasmid. Logarithmically growing cells, grown in Ura-media, were treated with 0.04% MMS for 80 min prior to being processed for b-galactosidase activity, denoted on the x axis (Miller units*10 À1 ).
(B and C) (B) Time course analysis of Cln2-TAP accumulation during recovery of a wild-type and an isogenic gcn4D strain after synchronization with a-factor, with or without exposure to MMS. Porin served as a loading control for quantification in (C).
(D) Cell-cycle progression in MMS-treated gcn4D mutants. Logarithmically growing cells were synchronized in G1 by a-factor and were treated with MMS or left untreated. These cells were subsequently released into fresh media, and their progression through the cell cycle was monitored at the indicated time points by FACS.
(E) A working model for regulated nucleocytoplasmic trafficking of tRNA after DNA damage. In cells with DNA damage, a Mec1/Rad53-dependent signaling pathway, via yet to be identified downstream effector(s), impinges on the export process via differential relocalization of Los1 to the cytoplasm. The ensuing nuclear accumulation of tRNA signals activation of Gcn4, which, in turn, contributes to the execution of the G1 checkpoint by delaying the accumulation of cyclin Cln2, and likely other key regulators of G1 progression.
unperturbed growth, they did not display the MMS-induced increase in b-galactosidase activity normally seen in wild-type cells ( Figure 7A ). Parenthetically, the requirement for Rad53 is a salient feature that distinguishes the MMS-induced response, with respect to upstream signaling, from a general stress response ( Figure S8 ). Moreover, deletion of LOS1 led to the constitutive activation of Gcn4 and concomitantly abrogated an additional MMS-induced increase in b-galactosidase activity ( Figure 7A ). These results illustrate that Gcn4 activation after MMS treatment occurred via a regulatory network that minimally comprised Rad53 signaling and Los1 as a downstream effector. It follows that, as with the gross defect in tRNA export in a los1 null mutant, the more subtle perturbations in tRNA trafficking also autonomously signaled Gcn4 activation after DNA damage. We next examined how the Rad53-mediated activation of Gcn4 contributes to maintaining homeostasis in cells with DNA damage. As a downstream effector of Rad53, deletion of GCN4, similar to that in a rad53 null mutant ( Figure 6D ), is expected to result in premature accumulation of Cln2 after MMS treatment, To examine this idea, wild-type and an isogenic gcn4D mutant that harbor a TAP-tagged allele of Cln2 were synchronized in G1 by a-factor treatment and subsequently treated with MMS prior to release from G1 arrest. While untreated wildtype and gcn4 strains accumulated Cln2-TAP at comparable rates, accumulation of Cln2-TAP in MMS-treated gcn4D mutants followed a considerably faster kinetic relative to that of the wild-type cells ( Figure 7B , quantification in Figure 7C ). In line with their premature accumulation of Cln2-TAP, gcn4D cells also failed to execute a G1 checkpoint ( Figure 7D ), thereby providing an explanation for their enhanced MMS sensitivity (Begley et al., 2004) . These data illustrate that deletion of GCN4 phenocopies the G1 checkpoint deficiency normally observed in a rad53 mutant, consistent with its role as a downstream component of DNA-damage signaling.
DISCUSSION
As essential components of the protein translation machinery, tRNAs function as fundamental regulators of cell growth and proliferation. The primary transcripts of the noncoding tRNAs are subject to extensive processing, which belies their apparent functional simplicity. While the core components of the processing machineries are well defined, the potential for selective regulation of tRNA processing in response to biological cues remains largely unexplored.
Here, we have shown that in budding yeast downregulation of tRNA export constitutes a previously unanticipated regulatory mode that contributes to the proper execution of the G1 checkpoint. Mechanistically, this response is mediated via Rad53-dependent differential localization of the Los1 export factor to the cytoplasm in cells with DNA damage ( Figure 4E ). This is a compelling example of a regulatory mechanism that elicits a robust cellular response by impinging on Los1, a limiting component of the tRNA export ( Figure S4 ). The resulting nuclear accumulation of unspliced tRNA signals Gcn4 activation and the subsequent execution of the G1 checkpoint. Failure to accumulate tRNA after genotoxic stress in rad53 mutants ( Figure 3C ) contributes to their deficiency in the G1 checkpoint. Conversely, deletion of LOS1 restores the G1 checkpoint in a rad53 mutant ( Figure 5B , lanes 6 and 8) because it autonomously signals the activation of Gcn4 ( Figure 7A ). These data collectively illustrate that the tRNA export process serves as an entry point for Rad53 signaling, which serves to transduce information about the integrity of the genome to the protein-synthesis machinery in the cytoplasm ( Figure 7E ). Consistent with its physiological significance, failure to execute this response results in elevated loss of viability after DNA damage ( Figure 5C ).
Large-scale studies with synthetic genetic arrays (Tong et al., 2004) and proteomics approaches (Gavin et al., 2006) have proven highly informative in in vivo mapping of the components of distinct functional modules in yeast. However, the potential for concerted regulation of these modules via their mutual functional interplay remains largely unknown because these qualitative data primarily portray static pictures of the cellular protein network topology. The data presented here illustrate a remarkable signal-mediated crosstalk between distinct functional modules, namely, tRNA nucleocytoplasmic trafficking, protein synthesis, and checkpoint execution. It highlights an interconnecting pathway that contributes to maintaining homeostasis via subtly quantifying the output of these functional modules. This regulatory network allows for functional coupling of tRNA biogenesis and cell-cycle progression, an observation in agreement with the tight correlation between proliferation rate and cellular protein synthesis capacity (Niwa and Walter, 2000) .
The aberrant tRNA accumulation in the nucleus in cells with DNA damage temporally precedes and autonomously signals G1 arrest via activation of the ubiquitous transcription factor Gcn4 ( Figure 7A ). Expression profiling with cDNA microarray has revealed that Gcn4 activation is accompanied by wide-spread reorganization of the cellular transcriptome (Hinnebusch and Natarajan, 2002) . The remodeling of the cellular transcriptional outlook by Gcn4 likely underlies its function in the G1 checkpoint. Genes encoding ribosomal proteins and general translation factors constitute the largest functional cluster among the genes repressed by Gcn4 (Natarajan et al., 2001 ). This partly accounts for the robust reduction in global protein translation in cells with DNA damage. Recovery from a DNA-damage-induced G1 arrest, unlike resumption of the cell cycle after a-factor arrest, requires de novo protein translation (Siede et al., 1994) . The Gcn4-mediated decrease in the output of the protein-synthesis machinery provides a rationale for the differential requirement for Gcn4 in the G1 checkpoint ( Figure 7D ).
The temporal requirement for protein synthesis in G1 progression is largely due to a requirement for an efficient rate of protein synthesis in translation of G1 cyclins (Polymenis and Schmidt, 1999) . Delayed translation of Cln2 is correlated with a G1 arrest after MMS exposure in wildtype cells ( Figure 6A ). Conversely, aberrant accumulation of Cln2 is concomitant with premature G1 progression in MMS-treated null mutants of RAD53 ( Figure 5B ) and its downstream effector GCN4 ( Figure 7D ). Consistent with a role for translational regulation of Cln2 in executing the G1 checkpoint, reducing the rate of Cln2 protein accumulation, by deleting LOS1, restores MMS-induced G1 arrest ( Figure 5B , lanes 6 and 8) and enhances viability in a checkpoint-defective rad53 mutant ( Figure 5C ). These data collectively reiterate the fundamental role of delayed Cln2 translation in the execution of the G1 checkpoint and further provide a plausible mechanistic basis for its execution ( Figure 7E ). Arguing for the conservation of the Cln2 function in the G1 checkpoint in higher eukaryotes, premature G1 progression via deregulated expression of G1 cyclin E in human epithelial cells is accompanied by increased loss of genomic stability, an observation in line with the elevated expression of cyclin E in a host of human tumors (Spruck et al., 1999) .
EXPERIMENTAL PROCEDURES Yeast Strains
All rad mutant strains were haploid isogenic derivatives of the wildtypeYMP10860: MATa ura3 leu2 trp1 his3 sml1 (Paulovich et al., 1997a) . C-terminally TAP-and GFP-tagged fusion strains, all derivatives of S288C, were as described (Ghaemmaghami et al., 2003; Huh et al., 2003) . Haploid yeast strains that harbor conditionally repressible tet alleles of the splicing endonucleases (Mnaimneh et al., 2004) were grown in YPD and were transferred to fresh YPD + 10 mg/ml doxycycline at 30 C for 12 hr in order to shut off expression from the tet promoters. LOS1 was disrupted with a CloneNAT-selectable cassette by using a standard one-step integration procedure (Wach et al., 1994) .
Induction of DNA Damage
Unless indicated otherwise, replicate cultures of log-phase cells in YPD media were treated with 0.04% MMS (Sigma Aldrich) for 80 min. For UV treatment, 30 ml cultures were grown to an A 600 of 0.2 in minimal SD media and were irradiated for 60 s with a 254 nm germicidal UV lamp at the dose rate of 1 J/m 2 /s while being stirred in a 15 cm Petri dish (Ghavidel and Schultz, 2001) . Viability was determined by the number of colonies normalized to that observed with untreated controls after 3 days of incubation at 30 C. The CEN-based expression plasmid that harbors the restriction endonuclease EcoRI under a galactose-inducible GAL promoter was as described (Mills et al., 1999) .
RNA Preparation and Analysis
Total yeast RNA were isolated and analyzed as described (Schmitt et al., 1990) . Northern blot procedure, including the sequence for individual oligonucleotide probes used for detecting select tRNA species, are as reported (O'Connor and Peebles, 1991) .
Protein Preparation and Analysis
Pelleted cells were disrupted with glass beads in lysis buffer (20 mM HEPES-KOH [pH 7.6], 120 mM ammonium sulfate, 1 mM EDTA, protease inhibitor cocktail [Roche], 2 mM DTT) with a single 30 s burst with a mini-bead beater (Biospec). After adding Triton X-100 to 0.25% (v/v), the lysate was incubated on ice for 30 min. Cellular debris was pelleted by microcentrifugation for 10 min. The protein supernatant was resolved in denaturing gels and examined by western blot essentially as described (Ghavidel and Schultz, 2001 ).
In Vitro tRNA Splicing Assay The in vitro splicing assay, performed with a tRNA Phe substrate, was done essentially as described (Reyes and Abelson, 1987) , with slight modifications as described in Supplemental Data.
Fluorescence Microscopy
The RNA in situ localization (FISH) was done as described (Sarkar and Hopper, 1998) . The quantification scheme for tRNA nucleocytoplasmic abundance is described in detail in Supplemental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and eight figures and can be found with this article online at http:// www.cell.org/cgi/content/full/131/5/915/DC1/.
